Testing a wearable patch ultrasound for liver stiffness
Part of Digestive system, Infections clinical trials.
This trial tests a new wearable patch that uses ultrasound to measure liver stiffness, which can help diagnose scarring. It may be an option if you already need or recently had a FibroScan for chronic liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or may have chronic liver disease (like hepatitis, fatty liver, or alcohol-related liver disease).
- You are 18 years or older.
- You are scheduled for or recently had a FibroScan (liver stiffness test) as part of your routine care.
- You do not have fluid buildup in your belly (ascites) or severe liver failure.
- You are not pregnant, have no skin issues on the right side of your ribcage, and have not had a liver transplant.
- Your body mass index (BMI) is under 35.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two non-invasive ultrasound methods (EUS-SWQ and FibroScan) with liver biopsy to see how well they detect liver scarring in patients with chronic liver disease. The goal is to improve how doctors diagnose and monitor liver damage from conditions like hepatitis B and fatty liver disease.
This study compares a handheld scanner (elastography device) with a standard scanner (iLivTouch) to measure liver stiffness in people with chronic hepatitis B, fatty liver disease, or related cirrhosis. The goal is to see how well the handheld device works, which could make liver testing easier and more accessible.
This trial uses a special ultrasound during endoscopy to measure liver and spleen stiffness. It may replace liver biopsy for some patients with cirrhosis or unexplained high liver enzymes.
This study tests a new, non-invasive way to measure liver stiffness using a device called FibroScan. It aims to make liver checkups easier and more comfortable for people with liver disease.
This study tests two new ultrasound techniques, Attenuation Imaging and Shear Wave Elastography, during a routine endoscopic ultrasound to see if they can accurately measure liver fat and stiffness in people whose standard FibroScan is normal. It may help doctors detect early liver changes more precisely.
This trial tests a special ultrasound technique during an endoscopy to see how well it can detect changes in the liver from non-alcoholic fatty liver disease. It may help improve non-invasive assessment before or alongside a follow-up liver biopsy.
Hear when a new Liver Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.